ArticleEvaluation of Some Methods forPreparing Glipizide-β-Cyclodextrin Inclusion Complexes Preparing glipizide-β-cyclodextrin inclusion complexes
Iranian Journal of Pharmaceutical Sciences,
Vol. 5 No. 4 (2009),
1 October 2009
,
Page 191-198
https://doi.org/10.22037/ijps.v5.41215
Abstract
Glipizide has been found to form inclusion complexes with β-cyclodextrin (β-CD) in solution and in solid state. The present study was undertaken to determine a suitable method for scaling up glipizide-β-CD inclusion complex formation and to evaluate the effect of some parameters on the efficiency of complexation. The solid inclusion complexes of glipizide and β-CD were prepared at a molar ratio of 1:1 and 1:2 by mixing, kneading, and co-precipitation methods both on small and large scales. The effect of parameters such as kneading time and temperature on complexation was also studied. Characterization was performed using infrared spectroscopy, X-ray diffractometry, and dissolution studies. In vitrorelease studies were carried out in phosphate buffer (pH 7.4). All the methods of preparation of complexes were found to be useful in increasing the solubility of glipizide except mixing method where the rise in solubility was not significant. Both kneading and co-precipitation methods in 1:2 molar ratios were found to be equally effective inimproving the solubility of glipizide. The formation of inclusion complexes was evident in these formulations as shown by IR and XRD studies. But when carried out on a large scale, co-precipitation method was found to be more tedious and time-consuming than kneading method. Moreover percent recovery of complexes in the kneading method was found to be 98.76% as compared to 92.05% in case of co-precipitation method. Drug content studies, IR spectroscopic studies, X-ray diffractometry studies andin vitrodissolution study data indicated that inclusion complexes prepared by kneading method in 1:2 molar ratios were suitable for improving the solubility of glipizide. The same formulation was prepared at large scale and optimum formulation conditions were established.
- β-Cyclodextrin
- Glipizide
- Inclusion complexes
- Kneading
How to Cite
References
[2]Ammar HO, El-Nahhas SA, Emara LH.Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation. Part 7.Trimethoprim Pharmazie1997; 52: 376-9.
[3]Chowdary KPR, Buchi NN. Nimesulide and β-cyclodextrin inclusion complexes:Physicochemical characterization and dissolution rate studies. Drug Dev Ind Pharm2000; 26:1217-20.
[4]Dhanraju MD, Kumaran K, Baskaran T, Moorty MS. Enhancement of bioavailability ofgriseofulvin by its complexation with β-cyclodextrin. Drug Dev Ind Pharm1998; 24:583-7.
[5]Hedges AR, Shieh WJ, Sikorski CT.Encapsulation and controlled release of food ingredients. In: Risch SJ, Reineccius GA ,(editors). ACS Symposium series No. 590.Washington: American Chemical Society, 1995;p. 60.
[6]Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 1996;85: 1017-25.
[7]Bruck SD. Controlled drug delivery. Vol.1. Boca Raton: CRC Press, 1983;pp. 125-48.
[8]Atwood JL, Davis JED, Mac Nicol DD. Inclusion compounds. Vol. III. London: Academic Press,1984, pp. 333-75.
[9]Linares MS, de Bertorello MM, Longhi MR.Effect of hydroxypropyl-β-cyclodextrin on the solubility of an antibacterial isoxazolyl-naphthoquinone. Drug Dev Ind Pharm2000; 26:1003-6.
[10]Moyano JR, Arias-Blanco MJ, Gines JM, Rabasco AM, Perez-Martinez JI. Dissolution behavior of oxazepam in presence of cyclodextrins:Evaluation of oxazepam-dimeb binary system.Drug Dev Ind Pharm1997; 23: 379-85.
[11]Redente E, Szente L, Szejtli J. Cyclodextrin complexes of salts of acidic drugs:thermodynamic properties, structural features,and pharmaceutical applications. J Pharm Sci 2001; 90: 979-86.
[12]Dollery SC. Therapeutic drugs. London: Churchill Livingstone, 1991.
[13]Parfitt K. Martindale, the complete drug reference.London: Pharmaceutical Press, 1999.
[14]Moyano JR, Arias-Blanco MJ, Gines JM, Rabasco AM, Perez-Martinez JI, Mor M, Giordano F.Nuclear magnetic resonance investigations of the inclusion complexation of glipizide with beta-cyclodextrin. J Pharm Sci 1997; 86: 72-5.
[15]Ozkan Y, Atay T, Dikmen, N, Iimer A, Aboul Enein HY. Improvement of water solubility and in vitrodissolution rate of glipizide by complexation with β-cyclodextrin. Int J Pharm1997; 148: 211-7.
[16]Winters CS, York P, Timmins P. Solid state examination of a glipizide-β- cyclodextrin complex. Eur J Pharm Sci1997; 5: 209-15.
[17]Higuchi T, Connors KA. Phase solubility techniques. Adv Anal Chem Instrum1965; 4:117-212.
- Abstract Viewed: 412 times
- IJPS_Volume 5_Issue 4_Pages 191-198 Downloaded: 187 times